MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 58 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390,863 | -32.1% | 81,600 | -2.9% | 0.00% | – |
| Q2 2023 | $575,825 | +48.1% | 84,062 | +68.4% | 0.00% | – |
| Q1 2023 | $388,893 | -35.4% | 49,922 | -36.9% | 0.00% | – |
| Q4 2022 | $602,323 | -30.7% | 79,149 | -25.6% | 0.00% | – |
| Q3 2022 | $869,000 | -28.8% | 106,327 | -15.8% | 0.00% | – |
| Q2 2022 | $1,221,000 | -41.0% | 126,240 | -14.5% | 0.00% | – |
| Q1 2022 | $2,070,000 | +54.4% | 147,674 | +124.9% | 0.00% | – |
| Q4 2021 | $1,341,000 | -24.3% | 65,656 | -17.4% | 0.00% | – |
| Q3 2021 | $1,771,000 | – | 79,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |